The European ESC-EORP-HFA Heart Failure Long Term Registry initially found both hypo- and hyperkalemia to be associated with poor clinical outcomes; however, after adjusting for the suspension of renin–angiotensin system inhibitors, hyperkalemia was not found to be associated with increased mortality [46]. This evidence concerns the gene REN and Hyperkalemia.